Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Depreciation and Depletion (2019 - 2026)

Pliant Therapeutics has reported Depreciation and Depletion over the past 8 years, most recently at $264000.0 for Q1 2026.

  • Quarterly Depreciation and Depletion fell 34.0% to $264000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Mar 2026, down 25.87% year-over-year, with the annual reading at $1.7 million for FY2025, 19.05% down from the prior year.
  • Depreciation and Depletion was $264000.0 for Q1 2026 at Pliant Therapeutics, down from $369000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $600000.0 in Q2 2024 and troughed at $264000.0 in Q1 2026.
  • The 5-year median for Depreciation and Depletion is $432000.0 (2022), against an average of $442411.8.
  • Year-over-year, Depreciation and Depletion soared 50.0% in 2024 and then plummeted 34.0% in 2026.
  • A 5-year view of Depreciation and Depletion shows it stood at $432000.0 in 2022, then decreased by 2.08% to $423000.0 in 2023, then grew by 2.36% to $433000.0 in 2024, then dropped by 14.78% to $369000.0 in 2025, then dropped by 28.46% to $264000.0 in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Depreciation and Depletion are $264000.0 (Q1 2026), $369000.0 (Q4 2025), and $400000.0 (Q3 2025).